AMP Stock Analysis: Ameriprise Financial | NYSE
Asset Management | NYSE, USA | Market Cap: 45.623m USD | 12M Return: -4.1% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 324M
EPS Trend: 98.9%
Qual. Beats: 1
Rev. Trend: 99.0%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Ameriprise Financial (AMP) is a large-cap U.S. diversified financial services company headquartered in Minneapolis, founded in 1894 and spun off as an independent public company in 2005 after previously operating as American Express Financial Corporation. It serves individual and institutional clients across the U.S. and internationally through four segments: Advice & Wealth Management (financial planning, brokerage, advisory accounts, mutual funds, insurance, annuities, and banking products); Asset Management (operated under the Columbia Threadneedle Investments brand, offering mutual funds, ETFs, separately managed accounts, hedge funds, and property/infrastructure funds); Retirement & Protection Solutions (variable annuities, life insurance, and disability income insurance); and Corporate & Other. The firm generates revenue from a mix of fee-based sources-including advisory and asset management fees tied to assets under management-along with insurance premiums and distribution income, a structure typical of diversified wealth and asset managers. It is classified within the GICS Asset Management & Custody Banks sub-industry.
- Columbia Threadneedle AUM climbs on equity market gains and net inflows
- Interest rate shifts impact variable annuity spreads and crediting rates
- Capital return accelerates via aggressive share buybacks and dividends
| Net Income: 3.90b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -2.82 > 1.0 |
| NWC/Revenue: -52.09% < 20% (prev 146.7%; Δ -198.8% < -1%) |
| CFO/TA 0.01 > 3% & CFO 1.67b > Net Income 3.90b |
| Net Debt (-2.53b) to EBITDA (4.82b): -0.52 < 3 |
| Current Ratio: 0.70 > 1.5 & < 3 |
| Outstanding Shares: last quarter (94.5m) vs 12m ago -5.50% < -2% |
| Gross Margin: 62.62% > 18% (prev 98.13%; Δ -35.51% > 0.5%) |
| Asset Turnover: 10.55% > 50% (prev 9.76%; Δ 0.80% > 0%) |
| Interest Coverage Ratio: 14.13 > 6 (EBIT TTM 4.61b / Interest Expense TTM 326.0m) |
| A: -0.05 (Total Current Assets 23.5b - Total Current Liabilities 33.5b) / Total Assets 184b |
| B: 0.15 (Retained Earnings 28.4b / Total Assets 184b) |
| C: 0.03 (EBIT TTM 4.61b / Avg Total Assets 182b) |
| D: 0.03 (Book Value of Equity 6.21b / Total Liabilities 178b) |
| Altman-Z'' = 0.35 = B |
| DSRI: 0.93 (Receivables 15.1b/14.8b, Revenue 19.2b/17.5b) |
| GMI: 1.57 (GM 98.13% / 62.62%) |
| AQI: 1.02 (AQ_t 0.87 / AQ_t-1 0.85) |
| SGI: 1.10 (Revenue 19.2b / 17.5b) |
| TATA: 0.01 (NI 3.90b - CFO 1.67b) / TA 184b) |
| Beneish M = -2.48 (Cap -4..+1) = BBB |
As of July 08, 2026, the stock is trading at USD 507.84 with a total of 553,835 shares traded. Over the past week, the price has changed by +13.66%, over one month by +13.01%, over three months by +17.97% and over the past year by -4.06%.
Current recommended Stop Loss: 476.50 (which is 6.2% or 2.5 ATR below the current price).
Ameriprise Financial has received a consensus analysts rating of 3.77. Therefore, it is recommended to hold AMP.
- StrongBuy: 5
- Buy: 1
- Hold: 6
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 543.6 | 7% |
P/E Trailing = 12.6527
P/E Forward = 11.3122
P/S = 2.3619
P/B = 7.0789
P/EG = 1.6395
Revenue TTM = 19.2b USD
EBIT TTM = 4.61b USD
EBITDA TTM = 4.82b USD
Long Term Debt = 5.61b USD (from longTermDebt, last quarter)
Short Term Debt = 200.0m USD (from shortTermDebt, last quarter)
Debt = 5.82b USD (corrected: LT Debt 5.61b + ST Debt 200.0m) + Leases 1.00m
Net Debt = -2.53b USD (calculated: Debt 5.82b - CCE 8.34b)
Enterprise Value = 43.1b USD (45.6b + Debt 5.82b - CCE 8.34b)
Interest Coverage Ratio = 14.13 (Ebit TTM 4.61b / Interest Expense TTM 326.0m)
EV/FCF = 25.76x (Enterprise Value 43.1b / FCF TTM 1.67b)
FCF Yield = 3.88% (FCF TTM 1.67b / Enterprise Value 43.1b)
FCF Margin = 8.72% (FCF TTM 1.67b / Revenue TTM 19.2b)
Net Margin = 20.30% (Net Income TTM 3.90b / Revenue TTM 19.2b)
Gross Margin = 62.62% ((Revenue TTM 19.2b - Cost of Revenue TTM 7.17b) / Revenue TTM)
Gross Margin QoQ = 50.31% (prev 53.57%)
Tobins Q-Ratio = 0.23 (Enterprise Value 43.1b / Total Assets 184b)
Interest Expense / Debt = 5.61% (Interest Expense 326.0m / Debt 5.82b)
Taxrate = 21.49% (1.07b / 4.96b)
NOPAT = 3.62b (EBIT 4.61b * (1 - 21.49%))
Current Ratio = 0.70 (Total Current Assets 23.5b / Total Current Liabilities 33.5b)
Debt / Equity = 0.94 (Debt 5.82b / totalStockholderEquity, last quarter 6.21b)
Debt / EBITDA = -0.52 (Net Debt -2.53b / EBITDA 4.82b)
Debt / FCF = -1.51 (Net Debt -2.53b / FCF TTM 1.67b)
Total Stockholder Equity = 6.32b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.14% (Net Income 3.90b / Total Assets 184b)
RoE = 61.59% (Net Income TTM 3.90b / Total Stockholder Equity 6.32b)
RoCE = 38.60% (EBIT 4.61b / Capital Employed (Equity 6.32b + L.T.Debt 5.61b))
RoIC = 2.41% (NOPAT 3.62b / Invested Capital 150b)
WACC = 8.97% (E(45.6b)/V(51.4b) * Re(9.55%) + D(5.82b)/V(51.4b) * Rd(5.61%) * (1-Tc(0.21)))
Discount Rate = 9.55% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -98.88 | Cagr: -4.86%
[DCF] Terminal Value 70.81% ; FCFF base≈3.67b ; Y1≈3.22b ; Y5≈2.60b
[DCF] Fair Price = 450.0 (EV 37.9b - Net Debt -2.53b = Equity 40.5b / Shares 89.9m; r=8.97% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 98.90 | EPS CAGR: 16.24% | SUE: 1.44 | # QB: 1
Revenue Correlation: 99.01 | Revenue CAGR: 8.08% | SUE: 0.67 | # QB: 0
EPS current Quarter (2026-06-30): EPS=10.61 | Chg30d=+0.24% | Revisions=+25% | Analysts=11
EPS next Quarter (2026-09-30): EPS=11.01 | Chg30d=-0.29% | Revisions=+25% | Analysts=9
EPS current Year (2026-12-31): EPS=44.43 | Chg30d=+0.59% | Revisions=+25% | GrowthEPS=+13.1% | GrowthRev=+6.3%
EPS next Year (2027-12-31): EPS=48.20 | Chg30d=+1.18% | Revisions=+25% | GrowthEPS=+8.5% | GrowthRev=+4.9%
[Analyst] Revisions Ratio: +57% (up=4, down=0)